Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canadian pricing review board enters into four compliance agreements in 1994.

Executive Summary

CANADIAN PRICING REVIEW BOARD ACCEPTED FOUR COMPLIANCE AGREEMENTS IN 1994, bringing the total number of voluntary compliance undertakings between pharmaceutical firms and the Canadian Patented Medicine Prices Review Board to 10. The four VCUs cover eight drug products. The agreements "involved price reductions and measures to offset excess revenues of $4.3 mil. including payments of $3.6 mil. to the Government of Canada," the January 1995 PMPRB "Bulletin" states. The PMPRB was established in December 1987 to regulate the prices of patented medicines. The first VCU action was in 1993.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel